Pearl Health Highlights Liability Gaps as Agentic AI Expands in Healthcare

According to a recent LinkedIn post from Pearl Health, the company is drawing attention to emerging liability gaps as autonomous, or “agentic,” AI tools gain traction in healthcare settings. The post highlights commentary from Chief Legal Officer Jonathan E. Goldin, who examines how current insurance products may not adequately address these risks.

The post suggests that traditional professional liability and tech errors and omissions policies may not neatly apply to autonomous AI agents making decisions in clinical or operational environments. It also points to specific risk categories such as hallucinations, unauthorized actions, and consent-related failures that reportedly remain largely uninsured today.

According to the post, healthcare operators and accountable care organizations could face heightened exposure as they adopt agentic AI without a corresponding evolution in insurance and risk-management frameworks. For investors, this may signal both a constraint and a catalyst: liability uncertainty could slow adoption, but companies that help define or navigate purpose-built AI risk solutions may gain strategic advantage.

Pearl Health’s focus on these issues appears aligned with broader value-based care trends, where financial outcomes are tied to clinical performance and operational efficiency. If the company is positioning itself as an early thought leader on AI governance and risk in this environment, it could enhance its standing with payers, providers, and potential partners that are evaluating AI-enabled models of care.

The post further implies that the current phase of agentic AI deployment in healthcare is still in its early stages from a regulatory and insurance standpoint. As frameworks mature, companies that have anticipated these challenges and integrated robust risk controls may be better positioned to scale AI-driven offerings and mitigate downside volatility in outcomes-based contracts.